G. Hockings

发表

Intragam can interfere with blood glucose monitoring

S. Kannan, Christine H Rowland, G. Hockings, 2004, The Medical journal of Australia.

Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans.

D. Torpy, J. Grice, G. Hockings, 1997, The Journal of clinical endocrinology and metabolism.

Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.

D. Torpy, J. Grice, G. Hockings, 1994, The Journal of clinical endocrinology and metabolism.

Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.

J. Grice, G. Hockings, E. J. Nye, 1999, The Journal of clinical endocrinology and metabolism.

Interactions Between the Stimulated Hypothalamic‐Pituitary‐Adrenal Axis and Leptin in Humans

D. Torpy, J. Grice, G. Hockings, 2000, Journal of neuroendocrinology.

The Insulin Hypoglycemia Test: Hypoglycemic Criteria and Reproducibility

D. Torpy, J. Grice, G. Hockings, 2001, Journal of neuroendocrinology.

NALOXONE‐INDUCED ACTH RELEASE IN MAN IS INHIBITED BY CLONIDINE

J. Grice, G. Hockings, R. Jackson, 1990, Clinical and experimental pharmacology & physiology.

Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.

D. Torpy, J. Grice, G. Hockings, 1993, The Journal of clinical endocrinology and metabolism.

Naloxone‐induced ACTH release: mechanism of action in humans

D. Torpy, J. Grice, G. Hockings, 1995, Clinical endocrinology.

Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.

J. Grice, G. Hockings, M. Walters, 1993, The Journal of clinical endocrinology and metabolism.

NALOXONE STIMULATION OF ACTH SECRETION DURING PETROSAL SINUS SAMPLING IN CUSHING'S SYNDROME

D. Torpy, J. Grice, G. Hockings, 1993, Clinical and experimental pharmacology & physiology.

Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.

D. Torpy, J. Grice, G. Hockings, 1994, The Journal of clinical endocrinology and metabolism.

EFFECT OF FLUMAZENIL ON BASAL AND NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

D. Torpy, J. Grice, G. Hockings, 1994, Clinical and experimental pharmacology & physiology.

DIURNAL EFFECTS OF FLUOXETINE AND NALOXONE ON THE HUMAN HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS

D. Torpy, J. Grice, G. Hockings, 1997, Clinical and experimental pharmacology & physiology.

The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.

D. Torpy, J. Grice, G. Hockings, 1995, The Journal of clinical endocrinology and metabolism.

Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.

D. Torpy, R. Azziz, L. Fox, 1998, The Journal of clinical endocrinology and metabolism.

Adrenocorticotropin stimulation tests in patients with hypothalamic‐pituitary disease: low dose, standard high dose and 8‐h infusion tests

D. Torpy, J. Grice, G. Hockings, 2001, Clinical endocrinology.

Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder

J. Grice, G. Hockings, M. Walters, 1993, Biological Psychiatry.

Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?

M. Brown, M. Marshall, T. Dwight, 2020, The Journal of clinical endocrinology and metabolism.

EFFECT OF SODIUM VALPROATE ON NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

D. Torpy, J. Grice, G. Hockings, 1995, Clinical and experimental pharmacology & physiology.

A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.

D. Torpy, J. Grice, G. Hockings, 1995, Neuroendocrinology.

Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy.

D. Torpy, J. Grice, G. Hockings, 1995, The Journal of clinical endocrinology and metabolism.

Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.

J. Grice, G. Hockings, M. Walters, 1993, Journal of Clinical Endocrinology and Metabolism.

L‐TYPE CALCIUM CHANNELS AND CRH‐MEDIATED ACTH AND CORTISOL RELEASE IN HUMANS

J. Grice, G. Hockings, M. Walters, 1991, Clinical and Experimental Pharmacology and Physiology.

CRH‐mediated pituitary‐adrenal responses are inhibited by nifedipine in humans

J. Grice, G. Hockings, A. J. Jackson, 1992, Neuroreport.

Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.

S. J. Fleming, A. Yap, G. Hockings, 1990, Clinical nephrology.

Inhibition of Naloxone‐Stimulated Adrenocorticotropin Release by Alprazolam in Myotonic Dystrophy Patients

D. Torpy, J. Grice, G. Hockings, 1998, Journal of neuroendocrinology.